150 related articles for article (PubMed ID: 649946)
1. Antibody titres in women six to eight years after the administration of RA2713 and Cendehill rubella vaccines.
Macdonald H; Tobin JO; Cradock-Watson JE; Lomax J
J Hyg (Lond); 1978 Jun; 80(3):337-47. PubMed ID: 649946
[TBL] [Abstract][Full Text] [Related]
2. Rubella in Orkney: seroepidemiology and vaccination.
Moffat MA; Heywood SN; Laughton E; Gould JJ; Freestone DS
J Hyg (Lond); 1977 Jun; 78(3):419-27. PubMed ID: 266542
[TBL] [Abstract][Full Text] [Related]
3. Specific immunoglobulin responses in serum and nasal secretions after the administration of attenuated rubella vaccine.
Cradock-Watson JE; Macdonald H; Ridehalgh MK; Bourne MS; Vandervelde EM
J Hyg (Lond); 1974 Aug; 73(1):127-41. PubMed ID: 4608331
[TBL] [Abstract][Full Text] [Related]
4. Studies on the reactogenicity and immunogenicity of the BRD-2 and RA27/3 live attenuated rubella vaccines.
Wang SS; Han YR; Su WN; Chen J; Zhao K
Vaccine; 1984 Dec; 2(4):277-80. PubMed ID: 6531968
[TBL] [Abstract][Full Text] [Related]
5. Rubella vaccination: persistence of antibodies for up to 16 years.
O'Shea S; Best JM; Banatvala JE; Marshall WC; Dudgeon JA
Br Med J (Clin Res Ed); 1982 Jul; 285(6337):253-5. PubMed ID: 6807437
[TBL] [Abstract][Full Text] [Related]
6. Neutralizing antibodies after rubella vaccination of newly delivered women: a comparison between three vaccines.
Grillner L
Scand J Infect Dis; 1975; 7(3):169-72. PubMed ID: 1237176
[TBL] [Abstract][Full Text] [Related]
7. Detection of rubella-specific serum IgG and IgA and nasopharyngeal IgA responses using a radioactive single radial immunodiffusion technique.
Al-Nakib W; Best JM; Banatvala JE
Clin Exp Immunol; 1975 Nov; 22(2):293-301. PubMed ID: 813933
[TBL] [Abstract][Full Text] [Related]
8. Rubella vaccination in Australia: 2. Experience with the RA27/3 rubella vaccine and results of a double-blind trial in schoolgirls.
Menser MA; Forrest JM; Bransby RD; Collins E
Med J Aust; 1978 Jul; 2(3):85-8. PubMed ID: 362141
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Wistar RA27/3 rubella virus vaccine in children.
Balfour HH; Balfour CL; Edelman CK; Rierson PA
Am J Dis Child; 1976 Oct; 130(10):1089-91. PubMed ID: 973611
[TBL] [Abstract][Full Text] [Related]
10. Fetal risk associated with rubella vaccine: an update.
Bart SW; Stetler HC; Preblud SR; Williams NM; Orenstein WA; Bart KJ; Hinman AR; Herrmann KL
Rev Infect Dis; 1985; 7 Suppl 1():S95-102. PubMed ID: 4001743
[TBL] [Abstract][Full Text] [Related]
11. HLA antigens and responses to rubella vaccination.
Harcourt GC; Best JM; Banatvala JE; Kennedy LA
J Hyg (Lond); 1979 Dec; 83(3):405-12. PubMed ID: 512353
[TBL] [Abstract][Full Text] [Related]
12. New Japanese rubella vaccine: comparative trials.
Best JM; Banatvala JE; Bowen JM
Br Med J; 1974 Jul; 3(5925):221-4. PubMed ID: 4602899
[TBL] [Abstract][Full Text] [Related]
13. Persistence of antibody induced by rubella vaccine (Wistar RA 27/3 strain) after six years.
Hillary IB; Freestone DS
J Hyg (Lond); 1975 Dec; 75(3):407-11. PubMed ID: 1059708
[TBL] [Abstract][Full Text] [Related]
14. Post-partum rubella immunisation: a controlled trial of two vaccines.
Black NA; Parsons A; Kurtz JB; McWhinney N; Lacey A; Mayon-White RT
Lancet; 1983 Oct; 2(8357):990-2. PubMed ID: 6138593
[TBL] [Abstract][Full Text] [Related]
15. Immunity to intranasal challenge with Rubella virus two years after vaccination: comparison of three vaccines.
Grillner L
J Infect Dis; 1976 Jun; 133(6):637-41. PubMed ID: 932491
[TBL] [Abstract][Full Text] [Related]
16. Response to experimental challenge in persons immunized with different rubella vaccines.
Fogel A; Gerichter CB; Barnea B; Handsher R; Heeger E
J Pediatr; 1978 Jan; 92(1):26-9. PubMed ID: 619075
[TBL] [Abstract][Full Text] [Related]
17. Persistence of rubella antibodies after vaccination: detection after experimental challenge.
Banatvala JE; Best JM; O'Shea S; Dudgeon JA
Rev Infect Dis; 1985; 7 Suppl 1():S86-90. PubMed ID: 4001741
[TBL] [Abstract][Full Text] [Related]
18. Rubella-specific serum and nasopharyngeal antibodies in volunteers with naturally acquired and vaccine-induced immunity after intranasal challenge.
Harcourt GC; Best JM; Banatvala JE
J Infect Dis; 1980 Aug; 142(2):145-55. PubMed ID: 7410897
[TBL] [Abstract][Full Text] [Related]
19. Development and persistence of class-specific antibodies in the serum and nasopharyngeal washings of rubella vaccinees.
O'Shea S; Best JM; Banatvala JE; Shepherd WM
J Infect Dis; 1985 Jan; 151(1):89-98. PubMed ID: 3965597
[TBL] [Abstract][Full Text] [Related]
20. Effect of low level immunity on response to live rubella virus vaccine.
Väänänen P; Mäkelä P; Vaheri A
Vaccine; 1986 Mar; 4(1):5-8. PubMed ID: 3962450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
